Country Club Bank Boosts Holdings in Cigna Group $CI

Country Club Bank grew its holdings in Cigna Group (NYSE:CI) by 18.1% during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 20,464 shares of the health services provider’s stock after acquiring an additional 3,135 shares during the period. Country Club Bank’s holdings in Cigna Group were worth $5,866,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also modified their holdings of CI. Wilsey Asset Management Inc. grew its stake in shares of Cigna Group by 2.9% during the 2nd quarter. Wilsey Asset Management Inc. now owns 101,936 shares of the health services provider’s stock valued at $33,698,000 after acquiring an additional 2,847 shares during the period. SCS Capital Management LLC lifted its holdings in Cigna Group by 39.1% during the second quarter. SCS Capital Management LLC now owns 30,633 shares of the health services provider’s stock valued at $10,127,000 after purchasing an additional 8,609 shares in the last quarter. Retirement Systems of Alabama lifted its holdings in Cigna Group by 3.9% during the second quarter. Retirement Systems of Alabama now owns 165,487 shares of the health services provider’s stock valued at $54,707,000 after purchasing an additional 6,155 shares in the last quarter. Modern Wealth Management LLC boosted its position in shares of Cigna Group by 91.3% in the first quarter. Modern Wealth Management LLC now owns 3,130 shares of the health services provider’s stock worth $1,030,000 after purchasing an additional 1,494 shares during the period. Finally, Janney Montgomery Scott LLC increased its stake in shares of Cigna Group by 3.9% in the second quarter. Janney Montgomery Scott LLC now owns 35,943 shares of the health services provider’s stock worth $11,882,000 after purchasing an additional 1,357 shares in the last quarter. Hedge funds and other institutional investors own 86.99% of the company’s stock.

Cigna Group Trading Down 0.8%

CI stock opened at $273.86 on Thursday. The firm has a fifty day moving average price of $278.63 and a 200 day moving average price of $293.24. Cigna Group has a fifty-two week low of $239.51 and a fifty-two week high of $350.00. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.76 and a current ratio of 0.76. The firm has a market cap of $73.16 billion, a PE ratio of 12.08, a price-to-earnings-growth ratio of 1.00 and a beta of 0.26.

Cigna Group (NYSE:CI) last released its quarterly earnings results on Thursday, October 30th. The health services provider reported $7.83 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $7.64 by $0.19. Cigna Group had a net margin of 2.29% and a return on equity of 18.80%. The company had revenue of $69.57 billion for the quarter, compared to the consensus estimate of $66.40 billion. During the same quarter in the prior year, the firm earned $7.51 earnings per share. Cigna Group’s revenue was up 9.5% on a year-over-year basis. Cigna Group has set its FY 2025 guidance at 29.600- EPS. Sell-side analysts anticipate that Cigna Group will post 29.77 earnings per share for the current fiscal year.

Cigna Group Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Thursday, December 18th. Investors of record on Thursday, December 4th will be given a $1.51 dividend. The ex-dividend date is Thursday, December 4th. This represents a $6.04 annualized dividend and a yield of 2.2%. Cigna Group’s dividend payout ratio (DPR) is currently 26.64%.

Wall Street Analyst Weigh In

A number of equities research analysts have issued reports on the company. Jefferies Financial Group reiterated a “buy” rating and issued a $310.00 price target on shares of Cigna Group in a research note on Monday, November 3rd. Barclays decreased their target price on Cigna Group from $383.00 to $300.00 and set an “overweight” rating on the stock in a research note on Friday, October 31st. Weiss Ratings restated a “hold (c)” rating on shares of Cigna Group in a research note on Monday. Sanford C. Bernstein reduced their price objective on shares of Cigna Group from $346.00 to $294.00 and set a “market perform” rating on the stock in a research report on Wednesday, November 12th. Finally, Truist Financial dropped their target price on shares of Cigna Group from $375.00 to $310.00 in a research report on Friday, October 31st. One equities research analyst has rated the stock with a Strong Buy rating, nineteen have issued a Buy rating, three have assigned a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $331.83.

Insider Activity

In related news, CEO David Cordani bought 4,134 shares of the company’s stock in a transaction dated Monday, November 3rd. The stock was purchased at an average price of $241.88 per share, for a total transaction of $999,931.92. Following the acquisition, the chief executive officer owned 157,935 shares in the company, valued at $38,201,317.80. This trade represents a 2.69% increase in their ownership of the stock. The purchase was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, insider Brian C. Evanko sold 5,368 shares of the stock in a transaction on Friday, October 3rd. The shares were sold at an average price of $300.00, for a total value of $1,610,400.00. Following the sale, the insider owned 51,182 shares in the company, valued at $15,354,600. The trade was a 9.49% decrease in their position. The disclosure for this sale is available in the SEC filing. Company insiders own 0.70% of the company’s stock.

About Cigna Group

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.